BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

9:17 PM
 | 
Jul 31, 2009
 |  BC Extra  |  Company News

Complete response for Restanza

Advanced Life Sciences Holdings Inc. (OTCBB:ADLS) received a complete response letter from FDA for Restanza cethromycin for the outpatient treatment of adults with mild-to-moderate community-acquired pneumonia (CAP)....

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >